N-(phenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | 68380-53-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N-(phenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
• 英文别名: 4-anilino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine；phenyl-(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine；Phenyl-(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amin；4-Anilino-1-phenyl-1H-pyrazolo<3,4-d>-pyrimidin；4-Anilino-1-phenyl-1H-pyrazolo<3,4-d>pyrimidin；4-(Phenylamino)-1-phenyl-1H-pyrazolo[3,4-D]pyrimidine；N,1-diphenylpyrazolo[3,4-d]pyrimidin-4-amine
• CAS: 68380-53-0
• 化学式: C₁₇H₁₃N₅
• 分子量: 287.324
• InChiKey: LGPHOPXOHBUOCX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  55.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  5-氨基-4-乙氧羰基-1-苯基吡唑 在 三氯氧磷 作用下， 以 异丙醇 为溶剂， 反应 0.83h， 生成 N-(phenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  参考文献：
  名称：

  Novel Dual Use of Formamide-POCl₃ Mixture for the Efficient, One-Pot Synthesis of Condensed 2H-Pyrimidin-4-amine Libraries Under Microwave Irradiation

  摘要：

  The novel dual use of formamide-POCl3 mixture for the incorporation of a C-N fragment to form the pyrimidine nucleus and its subsequent chlorination in an efficient, one-pot synthesis of potentially bioactive condensed 2H-pyrimidin-4-amine libraries under microwave irradiation (MWI) is reported. The one-pot microwave-assisted synthetic protocol is high-yielding, ecofriendly, rapid, and novel as well as eliminates intermittent work-ups. The protocol can be adapted for the library synthesis of series of a condensed pyrimidines.

  DOI：

  10.1080/00397911.2011.607934

文献信息

• [EN] PYRAZOLOPYRIMIDINES AS ANTI - HEPATITS C AGENTS<br/>[FR] PYRAZOLOPYRIMIDINES UTILISES COMME AGENTS ANTI-HEPATITE C
  申请人：ARROW THERAPEUTICS LTD

  公开号：WO2005047288A1

  公开（公告）日：2005-05-26

  Pyrazolopyrimidine derivatives of formula (I), or a pharmaceutically acceptable salt thereof, are found to be active against hepatitis C infection, wherein: R1 is C6-C10 aryl, 5- to 10- membered heteroary1, -(C1-C4 alkyl)-(C6-C10 aryl) or -(C1-C4 alkyl)-(5- to 10- membered heteroaryl); R2 is a C6-C10 aryl, C3-C6 carbocyclyl, 5- to 10- membered heteroaryl or 5- to 10- membered heterocyclyl moiety, said moiety being optionally fused to a C6­C10 aryl, C3-C6 carbocyclyl, 5- to 10- membered heteroaryl or 5- to 10­membered heterocyclic ring; and X is -NR'-, -NR'-CO-NR''-, -NR'-L, or -NR'-CO-L-, wherein R' and R'' are the same or different and each represent hydrogen or a C1-C6 alkyl group and L represents a C1-C6 alkylene group, the aryl, heteroaryl, heterocyclyl. and carbocyclyl moieties in the R1 and R2 substituents being unsubstituted or substituted by 1, 2 or 3 substituents selected from halogen, C1-C4 alkyl C1-C4alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano, nitro, C6-C10 aryl, C3-C6 carbocyclyl, 5- to 10- membered heterocyclyl, 5- to 10- membered heteroaryl, -NR'­CO2-R'', -CO2R'', -COR'''-NR'-CO-R''',-CONR'R'',SO2NR'R'',SO2R'''and -O-(CH2)n-R''' substituents, wherein n is from 0 to 4, each R’is the same or different and is hydrogen or C1-C6 alkyl, each R'' is the same or different and is hydrogen, C1-C6 alkyl, C6-C10 aryl, 5- to 10- membered heterocyclyl or 5- to 10- membered heteroaryl, each R''' is the same or different and is C1-C6 alkyl, C6-C10 aryl, 5- to 10- membered heterocyclyl or 5- to 10- membered heteroaryl, and each R'''' is the same or different and is C6-C10 aryl, 5- to 10- membered heterocyclyl or 5- to 10- membered heterocryl, the aryl, heteroaryl, heterocyclyl and carbocyclyl moieties in said substituents being unsubstituted or substituted by a further substituent selected from C1-C4 alkyl, C1-C4 hydroxyalkyl and C1-C4 haloalkyl groups.

  式(I)的吡唑啉衍生物，或其药用可接受的盐，被发现对丙型肝炎感染具有活性，其中：R1为C6-C10芳基，5-到10-成员杂芳基，-(C1-C4烷基)-(C6-C10芳基)或-(C1-C4烷基)-(5-到10-成员杂芳基)；R2为C6-C10芳基，C3-C6碳环烷基，5-到10-成员杂芳基或5-到10-成员杂环烷基基团，该基团可选择地与C6-C10芳基，C3-C6碳环烷基，5-到10-成员杂芳基或5-到10-成员杂环烷基环融合；X为-NR'-，-NR'-CO-NR''-，-NR'-L，或-NR'-CO-L-，其中R'和R''相同或不同，分别代表氢或C1-C6烷基，L代表C1-C6烷基基团，R1和R2取代基中的芳基，杂芳基，杂环烷基和碳环烷基基团未取代或通过1、2或3个卤素、C1-C4烷基、C1-C4烷氧基、C1-C4卤代烷基、C1-C4卤代烷氧基、氰基、硝基、C6-C10芳基、C3-C6碳环烷基、5-到10-成员杂环烷基、5-到10-成员杂芳基、-NR'-CO2-R''、- R''、-COR'''-NR'-CO-R'''、-CONR'R''、SO2NR'R''、SO2R'''和-O-(CH2)n-R'''取代。
• Potential Purine Antagonists. VI. Synthesis of 1-Alkyl- and 1-Aryl-4-substituted Pyrazolo[3,4-d]pyrimidines^1,2
  作者：C. C. CHENG、ROLAND K. ROBINS

  DOI：10.1021/jo01117a010

  日期：1956.11
• Design, synthesis &amp; evaluation of condensed 2H-4-arylaminopyrimidines as novel antifungal agents
  作者：Kishor S. Jain、Vijay M. Khedkar、Nikhilesh Arya、Prasad V. Rane、Pratip K. Chaskar、Evans C. Coutinho

  DOI：10.1016/j.ejmech.2014.02.066

  日期：2014.4

  A small, focussed library of condensed 2H-4-arylaminopyrimidines, with 3-diversity points, based on an initial design by molecular docking study of this scaffold at the active site of the fungal enzyme of cytochrome P-450 family, lanosterol 14 alpha-demethylase (CYP51) was synthesized through a one-pot green chemical synthetic protocol. The screening of the synthesised compounds for antifungal activity against Candida albicans, Aspergillus fumigatus & Aspergillus niger revealed activity in many of the compounds as comparable to that of fluconazole. Based on the antifungal activity and physicochemical property data of these derivatives, a meaningful SAR has been proposed. (c) 2014 Elsevier Masson SAS. All rights reserved.
• Tanji, Ken-ichi; Yokoi, Takeshi; Sugimoto, Osamu, Heterocycles, 2003, vol. 60, # 2, p. 413 - 418
  作者：Tanji, Ken-ichi、Yokoi, Takeshi、Sugimoto, Osamu

  DOI：——

  日期：——
• HAYASHI EISAKU; HIGASHINO TAKEO; SUZUKI SHIN-ICHI, YAKUGAKU DZASSI, YAKUGAKU ZASSNI, J. PHARM. SOS. JAR., 1978, 98, NO 1, 89+
  作者：HAYASHI EISAKU、 HIGASHINO TAKEO、 SUZUKI SHIN-ICHI

  DOI：——

  日期：——